Complete Guide to the Biotech, Pharmaceuticals & Genetics Industry From Plunkett Research 2020

August 13, 2019

HOUSTON, Texas – Plunkett Research, Ltd. announces an important market research and competitive analysis report, Plunkett’s Biotech, Pharmaceuticals & Genetics Industry Almanac, 2020 edition. A complete market research report, including forecasts and market estimates, technologies analysis and developments at innovative firms.

Biotechnology can be defined as the use of living organisms (such as bacteria), biological processes, or biological systems in order to create a desired end result or end product. Primary markets for biotechnology include: 1) Agriculture, where genetically-modified seeds are now in wide use in many nations. 2) The manufacture of enzymes for food processing or converting organic matter into ethanol for fuel. 3) Pharmaceuticals, where biotechnology creates such therapies as antibodies, interleukins and vaccines based on living organisms to target specific cellular conditions. Plunkett Research estimates that combined biotech revenues for publicly-held firms headquartered in the U.S. and E.U. will be $176 billion during 2018.

Key Findings:

  • Plunkett Research analyzes the top trends changing the industry, and provides in-depth industry statistics. In addition, this publication profiles the top 400 companies in the Biotech, Pharmaceuticals & Genetics Industry.

Available Formats:

  • Printed Almanac: ISBN 978-1-62831-542-4 (Available Now)
  • E-book: ISBN 978-1-62831-849-4 (Available Now)
  • Plunkett Research Online (Subscribers)

Key Features Include:

  • Industry trends analysis, market data and competitive intelligence
  • Market forecasts and Industry Statistics
  • Industry Associations and Professional Societies List
  • In-Depth Profiles of hundreds of leading companies
  • Industry Glossary
  • Link to 5-minute video overview of this industry

Pages: 518

Statistical Tables Provided: 16

Companies Profiled: 356

Geographic Focus: Global

Price: $379.99

Key Questions Answered Include:

  • How is the industry evolving?
  • How is the industry being shaped by new technologies?
  • How is demand growing in emerging markets and mature economies?
  • What is the size of the market now and in the future?
  • What are the financial results of the leading companies?
  • What are the names and titles of top executives?
  • What are the top companies and what are their revenues?

This feature-rich book covers competitive intelligence, market research and business analysis—everything you need to know about the biotech, pharmaceuticals & genetics business including:

  1. The State of the Biotechnology Industry Today
  2. A Short History of Biotechnology
  3. Fast Track Drugs Come to Market in the U.S. with FDA Cooperation
  4. Ethanol Production Soared, But U.S. Federal Subsidy Expires
  5. Cellulosic Ethanol Makes Slow Commercial Progress
  6. Major Drug Companies Acquire or Partner With Smaller Biotech Firms
  7. From Korea to India to Singapore to China, Nations Compete Fiercely in Biotech Development
  8. Patients’ Genetic Profiles Plummet in Price as DNA Sequencing Technologies Advance
  9. Gene Therapies Target Defective Genes/CRISPR Advances DNA Editing
  10. Vaccines and Viruses in Drug Delivery
  11. New Blockbuster Drugs Come to Market/ Drug Prices Soar
  12. Generic Drugs Have Biggest Market Share by Unit Volume, but not by Total Revenues
  13. Coupons and Other Marketing Schemes Obscure the Retail Prices of Drugs in the U.S., Which Are Vastly Higher than Prices Paid in Other Nations
  14. Biotech and Orphan Drugs Create New Revenues for Drug Firms
  15. Biosimilars (Generic Biotech Drugs) Receive FDA Guidelines for Accelerated Approval/ Competition Will Be Fierce
  16. Stem Cells—Multiple Sources Stem from New Technologies
  17. Stem Cells—Therapeutic Cloning Techniques Advance
  18. Stem Cells and 3-D Printing—A New Era of Tissue Replacement Takes Shape
  19. Genetically Modified (GM) Seeds and Crops Planted in Dozens of Nations/Agribio R&D Investment Is High
  20. Genetically Modified (GM) Foods Prompt Controversy, Labeling and Legislation
  21. Cloning of Farm Animals/Meat and Cheese Substitutes Created in Laboratories/3-D Printed Food Appears
  22. Selective Plant Breeding, Mutagenesis and Gene-Editing, Including CRISPR, as Alternatives to GM Seeds
  23. Immunotherapy and CAR-T Create Exciting New Approach to Fighting Cancers
  24. Technology Discussion—Genes and DNA
  25. Technology Discussion—Proteins and Proteomics
  26. Technology Discussion—DNA Chips
  27. Technology Discussion—SNPs (“Snips”)
  28. Technology Discussion—Synthetic Biology
  29. Technology Discussion—Recombinant DNA
  30. Technology Discussion—Polymerase Chain Reaction (PCR)

Biotech & Genetics Industry Statistics

  1. Biotech Industry Statistics and Market Size Overview
  2. The U.S. Drug Discovery & Approval Process
  3. U.S. FDA New Drug (NDA) and Biologic (BLA) Approvals, 2018
  4. U.S. Pharmaceutical R&D Spending Versus the Number of New Molecular Entity (NME)
    Approvals: 1993-2018
  5. Employment in Life & Physical Science Occupations by Business Type, U.S.: May 2018
  6. Federal R&D & R&D Plant Funding for Basic Research, U.S.: Fiscal Years 2018-2020
  7. U.S. Exports & Imports of Pharmaceutical Products: 2013-1st Quarter 2019
  8. U.S. Prescription Drug Expenditures, Aggregate & Per Capita Amounts, Percent Distribution: 2011-2027
  9. Prescription Drug Expenditures, U.S.: Selected Years, 1975-2027
  10. Total U.S. Biotechnology Patents Granted per Year by Patent Class: 1977-2015
  11. Research Funding for Biological Sciences, U.S. National Science Foundation: Fiscal Years
  12. Global Area of Biotech Crops by Country: 2017
  13. Domestic & Foreign Pharmaceutical Sales, PhRMA Member Companies: 1985-2018
  14. Sales By Geographic Area, PhRMA Member Companies: 2017
  15. Domestic U.S. Biopharmaceutical R&D & R&D Abroad, PhRMA Member Companies: 1985-2018
  16. Domestic U.S. Biopharmaceutical R&D & R&D Abroad Breakdown, PhRMA Member Companies: 2018

Companies Mentioned Include:

  • Vericel Corporation
  • Abaxis Inc
  • Abbott Laboratories
  • Abeona Therapeutics Inc
  • Insmed Inc
  • Affymetrix Inc
  • Agilent Technologies Inc
  • Akorn Inc
  • Albany Molecular Research Inc
  • Alcon Inc